Doctors call Wegovy’s new weight loss pill a game changer in the fight against obesity, but some experts are urging patients to be cautious.

Novo Nordisk stock fell 15% Monday after it said its next-generation weight loss drug didn't meet its primary target.

Novo Nordisk’s experimental weekly shot CagriSema was shown to lead to less dramatic weight loss compared to rival Lilly’s ...

Drugmakers Novo Nordisk and Eli Lilly are battling it out in the GLP-1 weight loss market. The pill version of Novo Nordisk's ...

Bailyn Fields has explained the symptoms to watch for and how to be sure of what the problem is ...

COPENHAGEN, Denmark — Novo Nordisk sued Hims and Hers Health on Monday over alleged patent infringement after the U.S. telehealth firm launched, then canceled, a $49 copy of Novo's weight-loss pill ...

Novo Nordisk, maker of Wegovy, saw its stock rise 6.5% after the opening bell on Monday. The company and the U.S. Food and Drug Administration threatened legal action against Hims & Hers, over its ...

Hims & Hers sent ripples through the pharmaceutical world by unveiling a weight-loss pill priced at just US$49 a month, but the headline-grabbing move failed to lift its battered stock Shares of the ...

Hims & Hers announced they are scrapping plans to sell a compounded version of the weight loss drug Wegovy after federal ...

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug and one day after the Food and Drug ...